Discover what non-reactive HIV test results really mean and why testing timing, window periods, and retesting are crucial for ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

Worldwide, at least seven people have been "cured" of HIV—or at least have had long-term sustained remission. This means that ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

A Report by Ghana HIV and AIDS Network (GHANET), as part of its Community HIV self-testing project, has revealed that petty traders across the country are at a high risk of HIV infection. They are ...